CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,259,084
+5.0%
289,871
+8.0%
0.01%0.0%
Q2 2023$19,288,230
+25.5%
268,414
+7.7%
0.01%
+20.0%
Q1 2023$15,365,598
-20.2%
249,118
-0.3%
0.01%
-16.7%
Q4 2022$19,264,760
+90.7%
249,770
+10.3%
0.01%
+50.0%
Q3 2022$10,100,000
+23.1%
226,353
+5.6%
0.00%
+33.3%
Q2 2022$8,208,000
-7.0%
214,286
+0.5%
0.00%0.0%
Q1 2022$8,825,000
+12.7%
213,213
+2.9%
0.00%
+50.0%
Q4 2021$7,830,000
+16.4%
207,230
+1.6%
0.00%0.0%
Q3 2021$6,726,000
-46.4%
204,052
+9.6%
0.00%
-50.0%
Q2 2021$12,554,000
+21.3%
186,095
+1.8%
0.00%0.0%
Q1 2021$10,353,000
-28.3%
182,842
+3.1%
0.00%
-33.3%
Q4 2020$14,442,000
+15.5%
177,267
+1.1%
0.01%0.0%
Q3 2020$12,499,000
-16.1%
175,413
-3.1%
0.01%
-14.3%
Q2 2020$14,896,000
+50.9%
181,040
+7.9%
0.01%
+16.7%
Q1 2020$9,874,000
-40.4%
167,830
+4.8%
0.01%
-33.3%
Q4 2019$16,556,000
+436.3%
160,178
+5.0%
0.01%
+350.0%
Q3 2019$3,087,000
+111.4%
152,511
+169.0%
0.00%
+100.0%
Q2 2019$1,460,000
+1985.7%
56,697
+220.3%
0.00%
Q1 2017$70,000
-41.7%
17,7000.0%0.00%
Q4 2016$120,000
-14.3%
17,7000.0%0.00%
Q3 2016$140,000
+4.5%
17,7000.0%0.00%
Q2 2016$134,00017,7000.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,008,508$82,980,00048.53%
Fairmount Funds Management LLC 216,098$17,781,0007.93%
WMS Partners, LLC 250,000$20,570,0004.26%
RTW INVESTMENTS, LP 1,658,316$136,446,0003.84%
MORGAN JESS S & CO INC 39,328$3,236,0003.51%
RA Capital Management 2,035,132$167,451,0003.26%
Ghost Tree Capital, LLC 100,000$8,228,0002.17%
ACUTA CAPITAL PARTNERS, LLC 90,000$7,405,0002.14%
Avidity Partners Management LP 404,900$33,315,0002.14%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,085,836$89,343,0001.97%
View complete list of AXSOME THERAPEUTICS INC shareholders